Mariko Taniguchi-Ikeda

Dr. Mariko Taniguchi-Ikeda

Department of Pediatrics, Osaka City University, Osaka, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Molecular Aspects of Medicine
Verified
Journal Article
Closed access
MTMariko Taniguchi-Ikeda
Mariko Taniguchi-Ikeda
IMIchiro Morioka
Ichiro Morioka
KIKazumoto Iijima
Kazumoto Iijima
TTTatsushi Toda
Tatsushi Toda

15 April 2021 in Brain
Verified
Journal Article
Open access
PDF file
EBElena Bonora
Elena Bonora
Sanjiban ChakrabartySanjiban Chakrabarty
Sanjiban Chakrabarty
GKGeorgios Kellaris
Georgios Kellaris
MTMakiko Tsutsumi
Makiko Tsutsumi
FBFrancesca Bianco
Francesca Bianco
Roberto De GiorgioRoberto De Giorgio
Roberto De Giorgio
Abnormal gut motility is a feature of several mitochondrial encephalomyopathies, and mutations in genes such as TYMP and POLG, have been linked to these rare diseases. The human genome encodes three DNA ligases, of which only one, ligase III (LIG3), has a mitochondrial splice variant and is crucial for mitochondrial health. We investigated the effect of reduced LIG3 activity and resulting mitochondrial dysfunction in seven patients from three independent families, who showed the common occurrence of gut dysmotility and neurological manifestations reminiscent of mitochondrial neurogastrointestinal encephalomyopathy. DNA from these patients was subjected to whole exome sequencing. In all patients, compound heterozygous variants in a new disease gene, LIG3, were identified. All variants were predicted to have a damaging effect on the protein. The LIG3 gene encodes the only mitochondrial DNA (mtDNA) ligase and therefore plays a pivotal role in mtDNA repair and replication. In vitro assays in patient-derived cells showed a decrease in LIG3 protein levels and ligase activity. We demonstrated that the LIG3 gene defects affect mtDNA maintenance, leading to mtDNA depletion without the accumulation of multiple deletions as observed in other mitochondrial disorders. This mitochondrial dysfunction is likely to cause the phenotypes observed in these patients. The most prominent and consistent clinical signs were severe gut dysmotility and neurological abnormalities, including leukoencephalopathy, epilepsy, migraine, stroke-like episodes, and neurogenic bladder. A decrease in the number of myenteric neurons, and increased fibrosis and elastin levels were the most prominent changes in the gut. Cytochrome c oxidase (COX) deficient fibres in skeletal muscle were also observed. Disruption of lig3 in zebrafish reproduced the brain alterations and impaired gut transit in vivo. In conclusion, we identified variants in the LIG3 gene that result in a mitochondrial disease characterized by predominant gut dysmotility, encephalopathy, and neuromuscular abnormalities.

30 September 2015 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
TNTaku Nakagawa
Taku Nakagawa
MTMariko Taniguchi-Ikeda
Mariko Taniguchi-Ikeda
YMYoshiko Murakami
Yoshiko Murakami
SNShota Nakamura
Shota Nakamura
DMDaisuke Motooka
Daisuke Motooka
KIKazumoto Iijima
Kazumoto Iijima

9 December 2016 in Scientific Reports
Verified
Journal Article
Open access
KMKaori Maeyama
Kaori Maeyama
IMIchiro Morioka
Ichiro Morioka
SISota Iwatani
Sota Iwatani
SFSachiyo Fukushima
Sachiyo Fukushima
DKDaisuke Kurokawa
Daisuke Kurokawa
KIKazumoto Iijima
Kazumoto Iijima
Gestational age (GA) is thought to affect height growth in small-for-gestational age (SGA) children. However, the GA-specific trajectories in body mass index (BMI) and early appearances of adiposity rebound (AR) have not been fully investigated in a cohort of Japanese SGA children. A longitudinal cohort study was conducted with 1063 SGA children born in Kobe, Japan, with sufficient records from birth to 3 years of age. Subjects were divided into subgroups based on GA: 39–41 weeks GA (n = 723), 37–38 weeks GA (n = 256), 34–36 weeks GA (n = 62), and <34 weeks GA (n = 22). Height and BMI were assessed at 4 months, 9 months, 1.5 years, and 3 years of age. The catch-up rate for height was GA-dependent. Most children with 39–41 weeks GA (91%) caught up by 4 months of age; however, lower GA was associated with a slower elevation in the catch-up rate. The BMI trajectory during the first 3 years was also GA-dependent, with a change in GA dependency at a boundary of 37 weeks GA. Approximately 7% of SGA children had already developed AR before 3 years of age. In conclusion, growth patterns during infancy and early childhood in SGA children differ depending on GA.

10 April 2020 in Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
RKRie Kawamura
Rie Kawamura
TKTakema Kato
Takema Kato
SMShunsuke Miyai
Shunsuke Miyai
FSFumihiko Suzuki
Fumihiko Suzuki
YNYuki Naru
Yuki Naru
MTMariko Taniguchi-Ikeda
Mariko Taniguchi-Ikeda
Sex-chromosome discordant chimerism (XX/XY chimerism) is a rare chromosomal disorder in humans. We report a boy with ambiguous genitalia and hypospadias, showing 46,XY[26]/46,XX[4] in peripheral blood cells. To clarify the mechanism of how this chimerism took place, we carried out whole-genome genotyping using a SNP array and microsatellite analysis. The B-allele frequency of the SNP array showed a mixture of three and five allele combinations, which excluded mosaicism but not chimerism, and suggested the fusion of two embryos or a shared parental haplotype between the two parental cells. All microsatellite markers showed a single maternal allele. From these results, we concluded that this XX/XY chimera is composed of two different paternal alleles and a single duplicated maternal genome. This XX/XY chimera likely arose from a diploid maternal cell that was formed via endoduplication of the maternal genome just before fertilization, being fertilized with both X and Y sperm.

15 December 2017 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
MTMariko Taniguchi-Ikeda
Mariko Taniguchi-Ikeda
NMN. Morisada
N. Morisada
HIH. Inagaki
H. Inagaki
YOY. Ouchi
Y. Ouchi
YTY. Takami
Y. Takami
KIK. Iijima
K. Iijima